Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Enrolling by invitation × Infections × 30 days × Clear all

Phase

Status

Recruiting 4 Enrolling by invitation 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 17 Breast Neoplasms 5 Prostatic Neoplasms 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Stomach Neoplasms 3 Melanoma 3 Lymphoma, Non-Hodgkin 3 Leukemia, Myeloid, Acute 3 Carcinoma, Renal Cell 3 Adenocarcinoma 3 Uterine Cervical Neoplasms 2 Urinary Bladder Neoplasms 2 Neoplasm Metastasis 2 Myelodysplastic Syndromes 2 Myasthenia Gravis 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Leukemia 2 Hematopoietic and Lymphatic System Neoplasm 2 Hematologic Diseases 2 Glioma 2 Gastrointestinal Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma 2 von Hippel-Lindau Disease 1 Uterine Neoplasms 1 Uterine Cervical Dysplasia 1 Triple Negative Breast Neoplasms 1 Thrombocytopenia 1 Squamous Intraepithelial Lesions of the Cervix 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07296263 2026-04-13

Contrast PMR

Hyperfine

Phase NA Enrolling by invitation

Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡